Taro Pharmaceutical Industries Ltd. (TARO) Holdings Trimmed by Northern Trust Corp

Northern Trust Corp lessened its stake in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 10.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 112,168 shares of the company’s stock after selling 13,309 shares during the quarter. Northern Trust Corp owned about 0.28% of Taro Pharmaceutical Industries worth $12,569,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Fort L.P. grew its holdings in Taro Pharmaceutical Industries by 2.1% during the 2nd quarter. Fort L.P. now owns 179,005 shares of the company’s stock valued at $20,059,000 after buying an additional 3,748 shares in the last quarter. Freestone Capital Holdings LLC grew its holdings in Taro Pharmaceutical Industries by 0.3% during the 2nd quarter. Freestone Capital Holdings LLC now owns 142,750 shares of the company’s stock valued at $15,996,000 after buying an additional 441 shares in the last quarter. River Road Asset Management LLC grew its holdings in Taro Pharmaceutical Industries by 33.3% during the 2nd quarter. River Road Asset Management LLC now owns 65,470 shares of the company’s stock valued at $7,337,000 after buying an additional 16,350 shares in the last quarter. NN Investment Partners Holdings N.V. grew its holdings in Taro Pharmaceutical Industries by 2.0% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 53,976 shares of the company’s stock valued at $6,049,000 after buying an additional 1,064 shares in the last quarter. Finally, Aperio Group LLC grew its holdings in Taro Pharmaceutical Industries by 46.9% during the 2nd quarter. Aperio Group LLC now owns 50,826 shares of the company’s stock valued at $5,696,000 after buying an additional 16,233 shares in the last quarter. 14.20% of the stock is owned by institutional investors and hedge funds.

WARNING: “Taro Pharmaceutical Industries Ltd. (TARO) Holdings Trimmed by Northern Trust Corp” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.com-unik.info/2017/11/03/taro-pharmaceutical-industries-ltd-taro-holdings-trimmed-by-northern-trust-corp.html.

TARO has been the subject of a number of research analyst reports. TheStreet downgraded Taro Pharmaceutical Industries from a “b-” rating to a “c+” rating in a research report on Wednesday, August 9th. BidaskClub downgraded Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th.

Taro Pharmaceutical Industries Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

What are top analysts saying about Taro Pharmaceutical Industries Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Taro Pharmaceutical Industries Ltd. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit